Blog - Novasign

Novasign Blog

Explore our case studies

Autonomous Continuous Biomanufacturing: Closing the Gap Between Process Development and Production

Continuous biomanufacturing has long been considered one of the most promising approaches to...

De‑Risking Bioprocess Scale‑Up: Predictive Modeling for Reliable Fermentation and Cell Culture Manufacturing

Media composition is one of the least transparent elements in modern cell culture bioprocess...

Next‑Generation Media Development: How Modeling Reduces Cost and Accelerates Bioprocess Optimization

Media composition is one of the least transparent elements in modern cell culture bioprocess...

Viral Vector Manufacturing: 64% Fewer Experiments in Lytic Virus Production

Hybrid Modeling for Efficient Process Development In a recent project with our strategic...

How to predict continuous ultrafiltration from batch experiments

In our latest publication on filtration, we show how a singular ultrafiltration experiment in...

Hybrid Modeling Meets Filtration: Optimizing UF and DF in Monoclonal Antibody Processing

Producing monoclonal antibodies often involves the challenge of balancing high protein...

Intensified DoE and hybrid modeling accelerate upstream process characterization

Process characterization is necessary for the biopharmaceutical industry to guarantee a...

Hybrid Models facilitate Scale-Up and Digital Twins for tangential flow filtration

Updated: May 28, 2020 The benefits of bioprocess modeling are well known:...